Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 40, No. 4, 2017

Issue release date: April 2017

Add all to MyReading List
Beilage
I

ONKOIMMUN 1/17

Oncol Res Treat 2017;40:I (DOI:10.1159/000478251)
MyKarger login required
Free Access
 
165

Editorial Board / Contents / Imprint

Oncol Res Treat 2017;40:165-166 (DOI:10.1159/000470881)
Free Access
Original Article
167

Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast Cancer

Abdeljaoued S. · Bettaieb I. · Nasri M. · Adouni O. · Goucha A. · El Amine O. · Boussen H. · Rahal K. · Gamoudi A.
Oncol Res Treat 2017;40:167-172 (DOI:10.1159/000458156)
174

Metastatic Melanoma: Treatment and Survival in the US after the Introduction of Ipilimumab and Vemurafenib

Enewold L. · Sharon E. · Harlan L.C.
Oncol Res Treat 2017;40:174-183 (DOI:10.1159/000456014)
185

Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy

Seker M. · Aydin D. · Bilici A. · Yavuzer D. · Ozgun M.G. · Ozcelik M. · Aydin O. · Aliustaoglu M.
Oncol Res Treat 2017;40:185-190 (DOI:10.1159/000456620)
192

Expression of Novel CD44st and MMP2 in NSCLC Tissues and Their Clinical Significance

Zhang L. · Li N. · Yan H.C. · Jiang H. · Fang X.J.
Oncol Res Treat 2017;40:192-196 (DOI:10.1159/000456669)
198

MET Amplification and Response to MET Inhibitors in Stage IV Lung Adenocarcinoma

Suryavanshi M. · Shah A. · Kumar D. · Panigrahi M.K. · Metha A. · Batra U.
Oncol Res Treat 2017;40:198-202 (DOI:10.1159/000457801)
203

Comparison Of Early-Stage High-Grade Serous Primary Fallopian Tube Cancers and Epithelial Ovarian Cancers: A Multicenter Study

Gungorduk K. · Ozdemir A. · Selcuk I. · Telli E. · Şahin Ö. · Toptaş T. · Akman L. · Güzel A.B. · Taşkın S. · Öge T. · Güngördük Ö. · Gokçü M. · Gungor T. · Yaşar L. · Terek M.C. · Ozan H. · Ozsaran A. · Sancı M. · Vardar M.A. · Meydanlı M.M. · Yalçın Ö.T. · Ortac F. · Özalp S.
Oncol Res Treat 2017;40:203-206 (DOI:10.1159/000458440)
207

Re-Irradiation of Locoregional NSCLC Recurrence Using Robotic Stereotactic Body Radiotherapy

Ceylan C. · Hamacı A. · Ayata H. · Berberoglu K. · Kılıç A. · Güden M. · Engin K.
Oncol Res Treat 2017;40:207-214 (DOI:10.1159/000457129)
Novel Insights from Clinical Practice
216

Non-Malignant Cerebrospinal Fluid Ascites in a Patient with Atypical Teratoid Rhabdoid Tumor

Upadhyaya S.A. · Klimo Jr. P. · Robinson G.W.
Oncol Res Treat 2017;40:216-219 (DOI:10.1159/000458441)
 
220

Society Bulletins

Oncol Res Treat 2017;40:220-224 (DOI:10.1159/000470440)
Free Access
225

PharmaForum

Oncol Res Treat 2017;40:225 (DOI:10.1159/000470888)
Free Access
226

PharmaForum

Oncol Res Treat 2017;40:226-227 (DOI:10.1159/000470889)
Free Access
229

PharmaForum

Oncol Res Treat 2017;40:229 (DOI:10.1159/000470890)
Free Access
231

PharmaNews

Oncol Res Treat 2017;40:231-232 (DOI:10.1159/000470891)
Free Access
234

Meetings and Conferences

Oncol Res Treat 2017;40:234-235 (DOI:10.1159/000470414)
Free Access